Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma. Clinical pharmacokinetics and safety

Clin Rev Allergy Immunol. Spring-Summer 1999;17(1-2):213-21. doi: 10.1007/BF02737605.
No abstract available

Publication types

  • Review

MeSH terms

  • Asthma / drug therapy*
  • Chronic Disease
  • Clinical Trials as Topic
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / analogs & derivatives*
  • Hydroxyurea / pharmacokinetics
  • Hydroxyurea / therapeutic use
  • Leukotriene Antagonists / adverse effects*
  • Leukotriene Antagonists / pharmacokinetics*
  • Leukotriene Antagonists / therapeutic use
  • Time Factors

Substances

  • Leukotriene Antagonists
  • zileuton
  • Hydroxyurea